Department of Internal Medicine Cardiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA.
J Biol Chem. 2010 May 28;285(22):16623-31. doi: 10.1074/jbc.M109.098236. Epub 2010 Apr 6.
Regulator of calcineurin 1 (RCAN1) inhibits the protein phosphatase calcineurin and is required for appropriate immune responses, synaptic plasticity, vascular tone, angiogenesis, and cardiac remodeling. Expression of the RCAN1-4 isoform is under the control of the calcineurin-responsive transcription factor NFAT. Typically, NFATs act in cooperation with other transcription factors to achieve maximal activation of gene expression. In this study, we identify the CCAAT/enhancer binding protein beta (C/EBPbeta) as an NFAT binding partner that cooperates with NFAT to regulate RCAN1-4 expression. Numerous C/EBPbeta binding sites are conserved in the RCAN1-4 proximal promoter. Overexpression of C/EBPbeta increased activity of both the endogenous mouse Rcan1-4 gene and a human RCAN1-4 luciferase reporter. Binding of C/EBPbeta to multiple sites in the promoter was verified using electrophoretic mobility shift assays and chromatin immunoprecipitation. A direct interaction between C/EBPbeta and NFAT was demonstrated by co-immunoprecipitation of proteins and complex formation at NFAT-C/EBPbeta composite sites. Depletion of endogenous C/EBPbeta decreased maximal activation of RCAN1-4 expression by calcineurin, whereas inhibition of calcineurin did not alter the ability of C/EBPbeta to activate RCAN1-4 expression. Together, these findings suggest that calcineurin/NFAT activation of RCAN1-4 expression is in part dependent upon C/EBPbeta, whereas activation by C/EBPbeta is not dependent on calcineurin and may provide a calcineurin-independent pathway for regulating RCAN1-4 expression. Importantly, nuclear localization, C/EBPbeta DNA binding activity and occupancy of the Rcan1-4 promoter increased in mouse models of heart failure demonstrating in vivo activation of this pathway to regulate Rcan1-4 expression and ultimately shape the dynamics of calcineurin-dependent signaling.
钙调神经磷酸酶 1(RCAN1)调节剂抑制蛋白磷酸酶钙调神经磷酸酶,是适当免疫反应、突触可塑性、血管张力、血管生成和心脏重塑所必需的。RCAN1-4 同种型的表达受钙调神经磷酸酶反应性转录因子 NFAT 的控制。通常,NFAT 与其他转录因子合作以实现基因表达的最大激活。在这项研究中,我们确定 CCAAT/增强子结合蛋白β(C/EBPβ)为与 NFAT 合作调节 RCAN1-4 表达的 NFAT 结合伙伴。RCAN1-4 近端启动子中保守了许多 C/EBPβ 结合位点。C/EBPβ 的过表达增加了内源性小鼠 Rcan1-4 基因和人类 RCAN1-4 荧光素酶报告基因的活性。使用电泳迁移率变动分析和染色质免疫沉淀验证了 C/EBPβ 在启动子多个位点的结合。通过共免疫沉淀蛋白质和在 NFAT-C/EBPβ 复合位点形成复合物,证明了 C/EBPβ 和 NFAT 之间的直接相互作用。内源性 C/EBPβ 的耗竭降低了钙调神经磷酸酶对 RCAN1-4 表达的最大激活,而钙调神经磷酸酶的抑制并未改变 C/EBPβ 激活 RCAN1-4 表达的能力。总之,这些发现表明,钙调神经磷酸酶/NFAT 对 RCAN1-4 表达的激活部分依赖于 C/EBPβ,而 C/EBPβ 的激活不依赖于钙调神经磷酸酶,并且可能为调节 RCAN1-4 表达提供了一种钙调神经磷酸酶非依赖性途径。重要的是,在心力衰竭的小鼠模型中观察到核定位、C/EBPβ DNA 结合活性和 Rcan1-4 启动子的占有率增加,证明了该途径的体内激活可调节 Rcan1-4 表达,并最终塑造钙调神经磷酸酶依赖性信号转导的动态。